A detailed history of Bessemer Group Inc transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Bessemer Group Inc holds 85 shares of URGN stock, worth $919. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85
Holding current value
$919
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$12.7 - $17.92 $1,079 - $1,523
85 New
85 $1,000
Q1 2019

May 13, 2019

SELL
$35.47 - $54.55 $7,200 - $11,073
-203 Closed
0 $0
Q3 2018

Nov 06, 2018

BUY
$41.65 - $51.7 $8,454 - $10,495
203 New
203 $10,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $246M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.